ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
50 |
14K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
50
|
14K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
volvoman
|
91 |
23K |
13 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
91
|
23K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
volvoman
|
15 |
3.2K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
15
|
3.2K
|
4
|
|
ASX - By Stock
|
BOQ |
Re:
General Discussion
|
|
volvoman
|
333 |
193K |
2 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
333
|
193K
|
2
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
50 |
14K |
3 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
50
|
14K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
44K
|
21M
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
volvoman
|
159 |
39K |
14 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
39K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FIH Data Confirms Optimal Valve Positioning with ComASUR
|
|
volvoman
|
14 |
5.8K |
9 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
14
|
5.8K
|
9
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
44K
|
21M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
44K
|
21M
|
5
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
20 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
44K
|
21M
|
20
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
150K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
331
|
150K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
22 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
44K
|
21M
|
22
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
5 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
44K
|
21M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
10K |
3.0M |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
10K |
3.0M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
50 |
14K |
4 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
50
|
14K
|
4
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
150K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
331
|
150K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
0 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
2 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
45
|
11K
|
6
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
150K |
19 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
331
|
150K
|
19
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
volvoman
|
331 |
150K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
331
|
150K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
4 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves
|
|
volvoman
|
45 |
11K |
18 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
45
|
11K
|
18
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
44K
|
21M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
volvoman
|
671 |
238K |
8 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
671
|
238K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
volvoman
|
88 |
34K |
6 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
88
|
34K
|
6
|
|
ASX - By Stock
|
BOQ |
Re:
General Discussion
|
|
volvoman
|
333 |
193K |
4 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
333
|
193K
|
4
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
50 |
14K |
7 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
50
|
14K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
1 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
44K
|
21M
|
1
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
volvoman
|
44K |
21M |
13 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
44K
|
21M
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
volvoman
|
209 |
55K |
8 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
209
|
55K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
volvoman
|
209 |
55K |
14 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
209
|
55K
|
14
|
|
ASX - By Stock
|
PLS |
Re:
PLS chart
|
|
volvoman
|
22K |
10M |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
22K
|
10M
|
0
|
|
ASX - By Stock
|
MCT |
Re:
Ann: Yundamindra Investor Presentation
|
|
volvoman
|
50 |
14K |
8 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
50
|
14K
|
8
|
|
ASX - By Stock
|
1MC |
Re:
Ann: Consolidation/Split - 1MC
|
|
volvoman
|
64 |
34K |
2 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
64
|
34K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
volvoman
|
85 |
21K |
26 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
21K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
volvoman
|
817 |
208K |
19 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
817
|
208K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
volvoman
|
43 |
15K |
1 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
43
|
15K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Letter from Automic
|
|
volvoman
|
31 |
20K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
31
|
20K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
volvoman
|
817 |
208K |
13 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
817
|
208K
|
13
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
11 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
37
|
19K
|
11
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
82K
|
49M
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
volvoman
|
82K |
49M |
8 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
82K
|
49M
|
8
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
5 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
37
|
19K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
10K |
3.0M |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
volvoman
|
10K |
3.0M |
9 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
BOQ |
Re:
Ann: 2024 Half Year Results Announcement
|
|
volvoman
|
37 |
19K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
37
|
19K
|
6
|
|